Models and modeling systems in Alzheimer disease drug discovery

Alzheimer Disease and Associated Disorders

Volumn 16, Issue SUPPL. 1, 2002, Pages

  Khachaturian, Zaven S ^a  

^a Radebaugh and Associates Inc   (United States)

Author keywords

Alzheimer; Drug discovery; Modeling systems; Models

Indexed keywords

ALZHEIMER DISEASE; ARTIFICIAL NEURAL NETWORK; COMPUTER; DEGENERATIVE DISEASE; DRUG RESEARCH; NEUROBIOLOGY; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 0036285725     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-200200001-00002     Document Type: Short Survey

References (44)

1. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
2. Identification of amyloid β protein in the brain of the small, short-lived lemurian primate Microcebus murinus
3. Neurodegenerative Alzheimerlike pathology in PDAPP 717V→F transgenic mice
4. β-amyloid accumulation correlates with cognitive dysfunction in the aged canine
5. The canine as an animal model of human aging and dementia
6. Selective loss of central cholinergic neurons in Alzheimer's disease
7. Ageing: The cholinergic hypothesis of cognitive decline
8. The medicinal chemistry of Alzheimer's and Alzheimer-like diseases with emphasis on the cholinergic hypothesis
9. Progress toward valid transgenic mouse models for Alzheimer's disease
10. The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies
11. Alzheimer's congress. Further progress on a β-amyloid vaccine
12. Transgenic mice expressing Alzheimer amyloid precursor proteins
13. Evidence for seeding of β-amyloid by intracerebral infusion of Alzheimer brain extracts in β-amyloid precursor protein-transgenic mice
14. The five-five, ten-ten plan for Alzheimer's disease
15. Scientific opportunities for developing treatments for Alzheimer's disease: Proceedings of research planning workshop I
16. The prospects of developing treatments for Alzheimer's disease
17. Prospects of developing interventions to prevent Alzheimer's disease
18. In silico drug discovery: Tools for bridging the NCE gap
19. Slowing the progression of Alzheimer disease: Methodologic issues
20. Rational design of an animal model for Alzheimer's disease: Introduction of multiple human genomic transgenes to reproduce AD pathology in a rodent
21. Promising vaccine treatment for Alzheimer's disease found
22. Alzheimer's disease: Transgenic models to test new chemicals and pharmaceuticals
23. Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human β-amyloid precursor protein
24. Building working cells 'in silico'
25. Homology of the amyloid β protein precursor in monkey and human supports a primate model for β amyloidosis in Alzheimer's disease
26. Transgenic model applications to drug discovery
27. Adaptation of the circular platform spatial memory task for mice: Use in detecting cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease
28. Aged non-human primates: An animal model of age-associated neurodegenerative disease
29. Alzheimer's disease: Genetic studies and transgenic models
30. Fisher symposium: Strategies for prevention of Alzheimer disease-overview of research planning meeting III
31. Animal models in the development of symptomatic and preventive drug therapies for Alzheimer's disease
32. Utilization of genetically altered animals in the pharmaceutical industry
33. Cellular and molecular biology of Alzheimer's disease and animal models
34. Transgenic approaches to model Alzheimer's disease
35. Transgenic animals in Alzheimer's disease research
36. In silico research in drug discovery
37. Prevention protocols for Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
38. The pharmacotherapy of Alzheimer's disease based on the cholinergic hypothesis: An update
39. A primate model of Alzheimer's disease
40. Clinical trial designs for demonstrating disease-course-altering effects in dementia
41. The older rabbit as an animal model: Implications for Alzheimer's disease
42. Human melanocytes as a model system for studies of Alzheimer's disease